February 14, 2024
You may also like
by earn
JEFFERIES ON GOLD FINANCIERS* RBI Flags Irregular Practices At Select Gold Financiers RBI Directs Gold Financiers To Review Processes, Identify Lapses And Take Remedial Measures In 3 Months Tighter Processes May Weigh On Growth, But Large Gold NBFCs Like Muthoot Should Be Better Placed Copied from stockaajorkal telegram channel IIFL Finance Should Be Unaffected, As It Has Already Taken Corrective Measures JEFFERIES ON GOLD FINANCIERS* RBI Flags Irregular Practices At Select Gold Financiers RBI Directs Gold Financiers To Review Processes, Identify Lapses And Take Remedial Measures In 3 Months Tighter Processes May Weigh On Growth, But Large Gold NBFCs Like Muthoot Should Be Better Placed Copied from stockaajorkal telegram channel IIFL Finance Should Be Unaffected, As It Has Already Taken Corrective Measures
JEFFERIES ON GOLD FINANCIERS* RBI Flags Irregular Practices At Select Gold Financiers RBI Directs Gold Financiers To Review Processes, Identify...
by earn
GOLDMAN SACHS ON NEULAND LABS • Reiterate Buy, target price 12,975 from Rs 11,400 • FDA approval for Cobenfy is a key event • FY26 Xanomile estimates to be up 55-60% • CDMO business multiple raised to 40x from 37x GOLDMAN SACHS ON NEULAND LABS • Reiterate Buy, target price 12,975 from Rs 11,400 • FDA approval for Cobenfy is a key event • FY26 Xanomile estimates to be up 55-60% • CDMO business multiple raised to 40x from 37x
GOLDMAN SACHS ON NEULAND LABS • Reiterate Buy, target price 12,975 from Rs 11,400 • FDA approval for Cobenfy is...
Comments are closed.